↓ Skip to main content

Dove Medical Press

Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect

Overview of attention for article published in Neuropsychiatric Disease and Treatment, June 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

blogs
1 blog
twitter
4 X users
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
110 Mendeley
Title
Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect
Published in
Neuropsychiatric Disease and Treatment, June 2014
DOI 10.2147/ndt.s30713
Pubmed ID
Authors

Kerri A Schoedel, Sarah A Morrow, Edward M Sellers

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Spain 1 <1%
Brazil 1 <1%
Unknown 106 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 12%
Other 12 11%
Student > Ph. D. Student 12 11%
Student > Doctoral Student 9 8%
Student > Bachelor 9 8%
Other 23 21%
Unknown 32 29%
Readers by discipline Count As %
Medicine and Dentistry 22 20%
Nursing and Health Professions 12 11%
Neuroscience 8 7%
Pharmacology, Toxicology and Pharmaceutical Science 8 7%
Psychology 8 7%
Other 16 15%
Unknown 36 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 August 2022.
All research outputs
#2,827,001
of 25,371,288 outputs
Outputs from Neuropsychiatric Disease and Treatment
#374
of 3,132 outputs
Outputs of similar age
#27,521
of 240,959 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#10
of 70 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,132 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 240,959 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.